The role of FDG PET/CT to omit sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer

Basit Öğe Kaydı
dc.contributor.authorSimsek, E. Tanrikulu
dc.contributor.authorCoban, E.
dc.contributor.authorAtag, E.
dc.contributor.authorGungor, S.
dc.contributor.authorSari, M.
dc.contributor.authorGurleyik, G.
dc.date.accessioned2025-05-10T19:48:31Z
dc.date.issued2021
dc.departmentİstanbul Medeniyet Üniversitesi
dc.descriptionESMO Breast Cancer Virtual Congress -- MAY 05-08, 2021 -- ELECTR NETWORK
dc.description.abstract[No abstract available]
dc.description.sponsorshipEuropean Soc Med Oncol
dc.identifier.doi10.1016/j.annonc.2021.03.081
dc.identifier.endpageS50
dc.identifier.issn0923-7534
dc.identifier.issn1569-8041
dc.identifier.scopusqualityQ1
dc.identifier.startpageS50
dc.identifier.urihttps://doi.org/10.1016/j.annonc.2021.03.081
dc.identifier.urihttps://hdl.handle.net/20.500.14730/11731
dc.identifier.volume32
dc.identifier.wosWOS:000648924400069
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.language.isoen
dc.publisherElsevier
dc.relation.ispartofAnnals of Oncology
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WOS_20250302
dc.titleThe role of FDG PET/CT to omit sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer
dc.typeConference Object

Dosyalar

Orijinal paket

Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
11731.pdf
Boyut:
80.37 KB
Biçim:
Adobe Portable Document Format
İndir

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu